Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-05

Clinical Trial Update: Impact of Umbilical Cord Cleansing With 4.0% Chlorhexidine on Neonatal Mortality [Phase 3]

View source ↗

Summary

Phase 3 trial assessing whether cleansing umbilical cords with 4.0% chlorhexidine reduces neonatal mortality due to omphalitis and infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine 4.0% (chlorhexidine)

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Omphalitis, Infection | Phase 3 | Status: COMPLETED